MCID: GNG009
MIFTS: 52

Gangliosidosis malady

Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Bone diseases, Metabolic diseases categories

Summaries for Gangliosidosis

About this section


Wikipedia:63 Gangliosidosis is a lipid storage disorder caused by the accumulation of lipids known as gangliosides.... more...

MalaCards based summary: Gangliosidosis, also known as disease, gangliosidosis, is related to tay-sachs disease and gangliosidosis gm1. An important gene associated with Gangliosidosis is HEXA (hexosaminidase A (alpha polypeptide)), and among its related pathways are Glycosphingolipid biosynthesis - ganglio series and Keratan sulfate/keratin metabolism. The compounds Ganglioside GA2 (d18:1/25:0) and Ganglioside GA2 (d18:1/24:0) have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and bone, and related mouse phenotypes are hearing/vestibular/ear and craniofacial.

Aliases & Classifications for Gangliosidosis

About this section

Gangliosidosis, Aliases & Descriptions:

Name: Gangliosidosis 9 11 43
Disease, Gangliosidosis 9
 
Gangliosidoses 60


Classifications:



External Ids:

Disease Ontology9 DOID:2368
SNOMED-CT55 50967008
MeSH33 D005733

Related Diseases for Gangliosidosis

About this section

Diseases in the Gangliosidosis family:

Gm1-Gangliosidosis, Type I Gm1-Gangliosidosis, Type Ii
Gm1-Gangliosidosis, Type Iii Gm2-Gangliosidosis, Ab Variant
Gangliosidosis Gm1 Gangliosidosis Gm2
Gm2 Gangliosidosis, 0 Variant Gm2-Gangliosidosis, B, B1, Ab Variant

Diseases related to Gangliosidosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 72)
idRelated DiseaseScoreTop Affiliating Genes
1tay-sachs disease30.9ARSA, GLA, HEXA, HEXB, GM2A, PSAP
2gangliosidosis gm130.8NEU1, PSAP, GLA, GLB1, ARSA, HEXA
3motor neuron disease30.8SMN1, HEXA, HEXB
4lysosomal storage disease30.7CTSA
5galactosialidosis30.6CTSA
6sandhoff disease, infantile, juvenile, and adult forms30.5GM2A, HEXB, HEXA, UGCG, ARSA
7dementia30.3ARSA, CHIT1, HEXA
8leukodystrophy30.2PSAP, GALC
9spinal muscular atrophy30.0SMN1, HEXA
10metachromatic leukodystrophy30.0PSAP, GALC, ARSA
11mucopolysaccharidosis30.0HEXA, HEXB, GLB1, GALNS, ARSA
12fabry disease29.7UGCG, CHIT1, PSAP, GLA, ARSA
13neuronitis10.5
14gm1-gangliosidosis, type i10.5
15gm1-gangliosidosis, type ii10.5
16gm1-gangliosidosis, type iii10.5
17dystonia10.5
18fucosidosis10.4HEXA
19mucolipidosis10.4ARSA, GLB1
20mucolipidosis ii alpha/beta10.3NEU1, GM2A, PSAP
21niemann-pick disease10.3CHIT1, PSAP
22gm2-gangliosidosis, ab variant10.2
23mongolian spot10.2
24cerebritis10.2
25gangliosidosis gm210.2
26gm2 gangliosidosis, 0 variant10.2
27gaucher's disease10.1PSAP, CHIT1, UGCG
28gaucher disease, type i10.1UGCG, CHIT1, PSAP
29mucopolysaccharidosis iv10.1CTSA, GALNS, GLB1, NEU1
30sphingolipidosis10.1ARSA, GALC, PSAP
31hepatitis10.1
32muscular atrophy10.1
33neuronal ceroid lipofuscinosis10.1
34sandhoff disease, infantile form10.1
35sandhoff disease, adult form10.1
36sandhoff disease, juvenile form10.1
37demyelinating disease10.0ARSA, GALC
38cystic fibrosis10.0SMN1, PTK2B, HEXA, GLB1
39metabolic syndrome x10.0HEXA, NEU1, GLA, CTSA, ARSA
40atherosclerosis10.0UGCG, CHIT1, GLA
41malaria9.9CHIT1, NEU1, PTK2B
42dihydropyrimidine dehydrogenase deficiency9.9
43prader-willi syndrome9.9
44insulin-like growth factor i9.9
45mucolipidosis iv9.9
46friedreich ataxia9.9
47burns9.9
48dilated cardiomyopathy9.9
49hydrocephalus9.9
50progressive muscular atrophy9.9

Graphical network of the top 20 diseases related to Gangliosidosis:



Diseases related to gangliosidosis

Symptoms for Gangliosidosis

About this section

Drugs & Therapeutics for Gangliosidosis

About this section

Drug clinical trials:

Search ClinicalTrials for Gangliosidosis

Search NIH Clinical Center for Gangliosidosis

Genetic Tests for Gangliosidosis

About this section

Anatomical Context for Gangliosidosis

About this section

MalaCards organs/tissues related to Gangliosidosis:

31
Brain, Liver, Bone, Skin, Testes, Globus pallidus, Bone marrow, Eye, Cerebellum, Whole blood, Cortex, Retina, Heart, Kidney, Salivary gland

Animal Models for Gangliosidosis or affiliated genes

About this section

Publications for Gangliosidosis

About this section

Articles related to Gangliosidosis:

(show top 50)    (show all 380)
idTitleAuthorsYear
1
A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis. (23337983)
2013
2
Natural history of infantile G(M2) gangliosidosis. (22025593)
2011
3
Rapid and simple polymerase chain reaction-based diagnostic assays for GM2 gangliosidosis variant 0 (Sandhoff-like disease) in Japanese domestic cats. (21398459)
2011
4
Gm1 gangliosidosis associated with neonatal-onset of diffuse ecchymoses and mongolian spots. (21572805)
2011
5
DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts. (20409738)
2010
6
Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis. (19765188)
2009
7
Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology. (19166507)
2009
8
Structural bases of GM1 gangliosidosis and Morquio B disease. (19644515)
2009
9
Brain proton magnetic resonance spectroscopy and neuromuscular pathology in a patient with GM1 gangliosidosis. (18184943)
2008
10
Juvenile-onset G(M2)-gangliosidosis in an African-American child with nystagmus. (18358410)
2008
11
Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis. (17994547)
2007
12
Neuroimaging findings in infantile GM1 gangliosidosis. (17052929)
2006
13
Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. (15687347)
2005
14
G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis. (15748609)
2005
15
Gene symbol: GLB1. Disease: GM1 gangliosidosis infantile. (15991326)
2005
16
Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. (16200419)
2005
17
Clinical and clinico-pathologic characteristics of Shiba dogs with a deficiency of lysosomal acid beta-galactosidase: a canine model of human GM1 gangliosidosis. (12655116)
2003
18
GM2 gangliosidosis variant B1 neuroradiological findings. (12527987)
2003
19
Molecular and structural studies of the GM2 gangliosidosis 0 variant. (12166653)
2002
20
Naturally occurring mutations in GM2 gangliosidosis: a compendium. (11596984)
2001
21
Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis. (10839995)
2000
22
Infantile G(M1) gangliosidosis: complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination. (10594135)
2000
23
Myelination arrest demonstrated using magnetic resonance imaging in a child with type I GM1 gangliosidosis. (9585685)
1998
24
Beta-Galactosidase gene mutations in patients with slowly progressive GM1 gangliosidosis. (9203065)
1997
25
Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. (9302266)
1997
26
Gangliosidosis in emus (Dromaius novaehollandiae). (7677649)
1995
27
Isolation and characterization of major urinary oligosaccharides excreted by a patient with type 3 GM1 gangliosidosis. (1917896)
1991
28
Ovine GM-1 gangliosidosis. (1750516)
1991
29
Molecular and clinical heterogeneity of adult GM2 gangliosidosis. (1840100)
1991
30
Juvenile GM2 gangliosidosis variant B1: clinical and biochemical study in seven patients. (2138256)
1990
31
Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase. (2140574)
1990
32
The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity. (2136940)
1990
33
Neurophysiological study in chronic GM2 gangliosidosis (hexosaminidase A and B deficiency), with motor neuron disease phenotype. (2793417)
1989
34
Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. (2949061)
1987
35
Reduced Ca2+ flux in synaptosomes from cats with GM1 gangliosidosis. (3121133)
1987
36
Movement disorders associated with chronic GM2 gangliosidosis. Case report and review of the literature. (3081350)
1986
37
Diagnosis and characterization of GM 2 gangliosidosis type II (Sandhoff disease) by analysis of the accumulating N-acetyl-glucosaminyl oligosaccharides with high performance liquid chromatography. (3955841)
1986
38
GM1 gangliosidosis (type 1) in a cat. (3091002)
1986
39
Presence of glycoproteins containing the polylactosamine structure in brain and liver of GM1 gangliosidosis patients. Comparative study between clinical types I and II, using endo-beta-galactosidase enzyme. (3088498)
1986
40
Characterization of neutral and acidic glycosphingolipids in brains of two patients with GM1 gangliosidosis type 1 and type 2. (3919156)
1985
41
Application of a GM1 ganglioside beta-galactosidase microassay method to diagnosis of GM1 gangliosidosis. (6432371)
1984
42
Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. (6614006)
1983
43
Neurotransmitter chemistry in feline GM1 gangliosidosis: a model for human ganglioside storage disease. (6126152)
1982
44
Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases. (6454083)
1981
45
Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features. (6791574)
1981
46
Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon. (7468596)
1981
47
Hepatic beta galactosidase and feline GMI gangliosidosis. (6799849)
1981
48
Leukocyte beta-galactosidase activity in the diagnosis of bovine GM1 gangliosidosis. (405787)
1977
49
Fatty acid composition of cholesterol esters in brains of patients with Schilder's disease, G M1 -gangliosidosis and Tay-Sachs disease, and its possible relationship to the -position fatty acids of lecithin. (5567894)
1971
50
Membranous cytoplasmic bodies from Tay-Sachs disease. Gm-1-gangliosidosis (generalized gangliosidosis). (5656560)
1968

Variations for Gangliosidosis

About this section

Expression for genes affiliated with Gangliosidosis

About this section
Search GEO for disease gene expression data for Gangliosidosis.

Pathways for genes affiliated with Gangliosidosis

About this section

Pathways related to Gangliosidosis according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
Ganglio Sphingolipid Metabolism36
9.8HEXA, HEXB, GLB1
2
Show member pathways
9.8GLB1, HEXB, HEXA
39.7GLA, HEXB, HEXA
4
Show member pathways
colanic acid building blocks biosynthesis36
N-acetylglucosamine degradation I36
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)36
UDP-D-xylose and UDP-D-glucuronate biosynthesis36
N-acetylglucosamine degradation II36
UDP-N-acetyl-D-glucosamine biosynthesis II36
UDP-N-acetyl-D-galactosamine biosynthesis II36
GDP-L-fucose biosynthesis I (from GDP-D-mannose)36
9.6CHIT1, HEXB, HEXA
59.5HEXA, HEXB, NEU1, GLB1
6
Show member pathways
9.5HEXA, HEXB, GLB1, GALNS
77.2GALC, GALNS, GLB1, GLA, PSAP, GM2A
8
Show member pathways
6.7ARSA, UGCG, CTSA, GALC, GLB1, GLA
9
Show member pathways
6.0ETFA, NEU1, HEXB, HEXA, UGCG, GM2A

Compounds for genes affiliated with Gangliosidosis

About this section
Sources:
24HMDB, 43Novoseek
See all sources

Compounds related to Gangliosidosis according to GeneCards Suite gene sharing:

(show top 50)    (show all 199)
idCompoundScoreTop Affiliating Genes
1Ganglioside GA2 (d18:1/25:0)249.7GM2A, NEU1, HEXB, GLB1, HEXA
2Ganglioside GA2 (d18:1/24:0)249.7NEU1, GM2A, HEXA, HEXB, GLB1
3Ganglioside GA2 (d18:1/24:1(15Z))249.7HEXA, HEXB, NEU1, GLB1, GM2A
4Ganglioside GA2 (d18:1/26:0)249.7GLB1, HEXA, HEXB, NEU1, GM2A
5Ganglioside GA2 (d18:1/9Z-18:1)249.7HEXB, NEU1, GLB1, GM2A, HEXA
6Ganglioside GA2 (d18:1/26:1(17Z))249.7HEXA, HEXB, NEU1, GM2A, GLB1
7Ganglioside GA2 (d18:1/22:0)249.7HEXA, HEXB, NEU1, GM2A, GLB1
8Ganglioside GA2 (d18:1/16:0)249.7HEXB, NEU1, GM2A, GLB1, HEXA
9Ganglioside GA2 (d18:1/12:0)249.7HEXA, HEXB, NEU1, GM2A, GLB1
10Ganglioside GA2 (d18:1/20:0)249.7GLB1, HEXA, HEXB, NEU1, GM2A
11Ganglioside GA2 (d18:1/18:0)249.7GLB1, GM2A, HEXA, HEXB, NEU1
12sulfatide439.4ARSA, GLB1, PSAP, GM2A, NEU1
13Ganglioside GM2 (d18:1/24:1(15Z))249.4GM2A, NEU1, HEXB, HEXA, GLB1
14Ganglioside GM2 (d18:1/18:0)249.4HEXB, GLB1, GM2A, NEU1, HEXA
15Ganglioside GM2 (d18:1/12:0)249.3GLB1, HEXA, HEXB, NEU1, GM2A
16Ganglioside GM2 (d18:1/22:0)249.3HEXA, HEXB, NEU1, GM2A, GLB1
17D-Galactose249.3GLA, GLB1, GALC, GALNS
18Ganglioside GM2 (d18:1/24:0)249.2HEXA, HEXB, NEU1, GM2A, GLB1
19Ganglioside GM2 (d18:1/16:0)249.0HEXA, HEXB, NEU1, GM2A, GLB1
20Trihexosylceramide (d18:1/9Z-18:1)248.5GALC, UGCG, HEXA, GM2A, GLA, HEXB
21Trihexosylceramide (d18:1/26:1(17Z))248.5UGCG, HEXA, HEXB, GM2A, GLA, GALC
22Trihexosylceramide (d18:1/24:0)248.5GALC, GLA, GM2A, HEXB, HEXA, UGCG
23Trihexosylceramide (d18:1/22:0)248.5GM2A, UGCG, HEXA, HEXB, GLA, GALC
24Trihexosylceramide (d18:1/25:0)248.5GM2A, GLA, GALC, UGCG, HEXA, HEXB
25Trihexosylceramide (d18:1/20:0)248.5UGCG, HEXA, HEXB, GM2A, GLA, GALC
26Lactosylceramide (d18:1/24:0)248.5UGCG, HEXA, HEXB, NEU1, GM2A, GALC
27Trihexosylceramide (d18:1/24:1(15Z))248.5UGCG, HEXA, HEXB, GM2A, GLA, GALC
28Lactosylceramide (d18:1/18:0)248.5UGCG, GALC, GM2A, NEU1, HEXB, HEXA
29Trihexosylceramide (d18:1/16:0)248.5GM2A, GLA, GALC, UGCG, HEXA, HEXB
30Lactosylceramide (d18:1/22:0)248.5GALC, GM2A, NEU1, HEXB, HEXA, UGCG
31Trihexosylceramide (d18:1/12:0)248.5UGCG, HEXA, HEXB, GM2A, GLA, GALC
32Trihexosylceramide (d18:1/18:0)248.5UGCG, HEXA, HEXB, GM2A, GLA, GALC
33Galactosylceramide (d18:1/20:0)248.4GALC, UGCG, NEU1, GM2A, GLA, ARSA
34Galactosylceramide (d18:1/22:0)248.3GALC, ARSA, GLA, GM2A, NEU1, UGCG
35Galactosylceramide (d18:1/24:1(15Z))248.3ARSA, GALC, GLA, GM2A, UGCG, NEU1
36Galactosylceramide (d18:1/18:1(9Z))248.3UGCG, ARSA, GALC, GLA, GM2A, NEU1
37Galactosylceramide (d18:1/16:0)248.3UGCG, GALC, GLA, GM2A, NEU1, ARSA
38Galactosylceramide (d18:1/18:0)248.3ARSA, GALC, GLA, GM2A, NEU1, UGCG
39Galactosylceramide (d18:1/26:1(17Z))248.3ARSA, GALC, GLA, GM2A, NEU1, UGCG
40mannose 6-phosphate43 249.2CTSA, GLA, PSAP, GM2A, NEU1, HEXA
41glucosylceramide43 249.1GALC, GLA, PSAP, GLB1, GM2A, CHIT1
42Lactosylceramide (d18:1/12:0)248.1HEXB, GALC, GLB1, GLA, GM2A, NEU1
43Lactosylceramide (d18:1/26:0)248.1GM2A, GLA, GLB1, GALC, NEU1, HEXB
44Lactosylceramide (d18:1/25:0)248.1UGCG, HEXA, HEXB, NEU1, GM2A, GLA
45Lactosylceramide (d18:1/26:1(17Z))248.1UGCG, HEXA, HEXB, NEU1, GM2A, GLA
46Lactosylceramide (d18:1/24:1(15Z))248.1UGCG, HEXA, HEXB, NEU1, GM2A, GLA
47Lactosylceramide (d18:1/16:0)248.1UGCG, HEXA, GALC, GLB1, GLA, GM2A
48ganglioside438.1PSAP, NEU1, HEXB, GLA, HEXA, UGCG
49glycolipid438.1GLA, GM2A, GALC, PSAP, NEU1, HEXB
50Water247.9ARSA, GALC, GLB1, GALNS, GLA, CHIT1

GO Terms for genes affiliated with Gangliosidosis

About this section

Cellular components related to Gangliosidosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lysosomeGO:00057648.3CHIT1, GLA, GALC, CTSA, ARSA, NEU1
2lysosomal lumenGO:00432027.0ARSA, HEXA, HEXB, NEU1, GM2A, PSAP

Biological processes related to Gangliosidosis according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1hyaluronan catabolic processGO:003021410.0HEXB, HEXA
2lysosome organizationGO:000704010.0HEXB, HEXA
3ganglioside catabolic processGO:000668910.0HEXA, HEXB, GM2A
4lipid storageGO:001991510.0GM2A, HEXB, HEXA
5oligosaccharide catabolic processGO:00093139.9GM2A, NEU1, HEXB
6chondroitin sulfate catabolic processGO:00302079.9HEXB, HEXA
7neuromuscular process controlling balanceGO:00508859.9HEXA, HEXB, GM2A
8keratan sulfate catabolic processGO:00423409.7HEXA, HEXB, GLB1, GALNS
9hyaluronan metabolic processGO:00302129.7HEXB, HEXA
10keratan sulfate metabolic processGO:00423399.7GALNS, GLB1, HEXB, HEXA
11glycosaminoglycan metabolic processGO:00302039.6HEXA, HEXB, GLB1, GALNS
12carbohydrate metabolic processGO:00059759.1GALC, GALNS, GLB1, HEXB, HEXA
13sphingolipid metabolic processGO:00066657.0ARSA, UGCG, CTSA, GALC, GLB1, GLA
14glycosphingolipid metabolic processGO:00066877.0GALC, GLB1, GLA, PSAP, GM2A, NEU1
15small molecule metabolic processGO:00442816.2ETFA, NEU1, HEXB, HEXA, UGCG, GM2A

Molecular functions related to Gangliosidosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1sulfuric ester hydrolase activityGO:00084849.9ARSA, GALNS
2beta-N-acetylhexosaminidase activityGO:00045639.7GM2A, HEXB, HEXA
3galactoside bindingGO:00169369.7GLB1, GLA

Products for genes affiliated with Gangliosidosis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Gangliosidosis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet